Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Takigawa

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Discoveries & Therapeutics|February 26, 2025
Characteristics and patterns of adverse event reports in the Japanese Adverse Drug Event Report database over two decades (2004-2023): Exploring findings on sexes and age groupsHiroyuki Tanaka, Masaki Takigawa, Naohito Ide, et al.
In Vivo (Athens, Greece)|April 30, 2024
Risk and Time-to-Onset of Acute Kidney Injury With Vancomycin Plus Piperacillin-tazobactam Combination: Analysis Using JADERNaohito Ide, Ken-Ichi Sako, Masaki Takigawa, et al.
Drugs & Aging|April 30, 2025
Risk Factors for Vancomycin-Induced Nephrotoxicity and Kidney Prognosis in Patients Aged 75 Years and Older: A Retrospective StudyMasaki Takigawa, Hiroyuki Tanaka, Masako Kinoshita, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Retrospective Study of Factors Affecting the Accuracy of Predicting Vancomycin Concentrations in Patients Aged 75 Years and AboveMasaki Takigawa, Hiroyuki Tanaka, Masako Kinoshita, et al.
Drug Discoveries & Therapeutics|June 18, 2023
Characteristics of adverse event reports among people living with human immunodeficiency virus (HIV) in Japan: Data mining of the Japanese Adverse Drug Event Report databaseHiroyuki Tanaka, Mitsutoshi Satoh, Masaki Takigawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 1, 2025
[Evaluation of the Usefulness of Pharmacy Lectures to Non-pharmaceutical Students Majoring in Life Sciences: A Questionnaire Survey]Mihoko Hayafune, Masaki Takigawa, Yasuhiro Sasaki, et al.
Cancer Diagnosis & Prognosis|January 12, 2023
Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance AnalysisMasaki Takigawa, Hiroyuki Tanaka, Hiromi Washiashi, et al.
Scientific Reports|February 4, 2024
Factors promoting research activities among Japanese pharmacists: a questionnaire surveyMasaki Takigawa, Yuki Kondo, Yutaka Kobayashi, et al.
Cureus|April 1, 2024
Elderly Woman With No Autoimmune Disease With Aseptic Meningitis Caused by CelecoxibMasaki Takigawa, Hiroyuki Tanaka, Takashi Kobayashi, et al.
Journal of Toxicologic Pathology|February 12, 2019
Age-dependent changes in vancomycin-induced nephrotoxicity in miceMasaki Takigawa, Hirofumi Masutomi, Yoshitomo Shimazaki, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Discoveries & Therapeutics|February 26, 2025
Characteristics and patterns of adverse event reports in the Japanese Adverse Drug Event Report database over two decades (2004-2023): Exploring findings on sexes and age groupsHiroyuki Tanaka, Masaki Takigawa, Naohito Ide, et al.
In Vivo (Athens, Greece)|April 30, 2024
Risk and Time-to-Onset of Acute Kidney Injury With Vancomycin Plus Piperacillin-tazobactam Combination: Analysis Using JADERNaohito Ide, Ken-Ichi Sako, Masaki Takigawa, et al.
Drugs & Aging|April 30, 2025
Risk Factors for Vancomycin-Induced Nephrotoxicity and Kidney Prognosis in Patients Aged 75 Years and Older: A Retrospective StudyMasaki Takigawa, Hiroyuki Tanaka, Masako Kinoshita, et al.
Medicina (Kaunas, Lithuania)|August 29, 2024
Retrospective Study of Factors Affecting the Accuracy of Predicting Vancomycin Concentrations in Patients Aged 75 Years and AboveMasaki Takigawa, Hiroyuki Tanaka, Masako Kinoshita, et al.
Drug Discoveries & Therapeutics|June 18, 2023
Characteristics of adverse event reports among people living with human immunodeficiency virus (HIV) in Japan: Data mining of the Japanese Adverse Drug Event Report databaseHiroyuki Tanaka, Mitsutoshi Satoh, Masaki Takigawa, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 1, 2025
[Evaluation of the Usefulness of Pharmacy Lectures to Non-pharmaceutical Students Majoring in Life Sciences: A Questionnaire Survey]Mihoko Hayafune, Masaki Takigawa, Yasuhiro Sasaki, et al.
Cancer Diagnosis & Prognosis|January 12, 2023
Time to Onset of Gemcitabine-induced Thrombotic Microangiopathy in a Japanese Population: A Case Series and Large-scale Pharmacovigilance AnalysisMasaki Takigawa, Hiroyuki Tanaka, Hiromi Washiashi, et al.
Scientific Reports|February 4, 2024
Factors promoting research activities among Japanese pharmacists: a questionnaire surveyMasaki Takigawa, Yuki Kondo, Yutaka Kobayashi, et al.
Cureus|April 1, 2024
Elderly Woman With No Autoimmune Disease With Aseptic Meningitis Caused by CelecoxibMasaki Takigawa, Hiroyuki Tanaka, Takashi Kobayashi, et al.
Journal of Toxicologic Pathology|February 12, 2019
Age-dependent changes in vancomycin-induced nephrotoxicity in miceMasaki Takigawa, Hirofumi Masutomi, Yoshitomo Shimazaki, et al.
Pageof 2